XML 18 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2020
Dec. 31, 2019
Assets:    
Cash and cash equivalents $ 14,869 $ 5,683
Investments 2,596 2,373
Accounts receivable, net 22,520 19,617
Inventories 16,519 17,516
Other current assets 6,002 5,113
Total current assets 62,506 50,302
Long-term investments 18,594 17,314
Property and equipment, net 12,221 12,044
Operating lease right-of-use assets 20,571 20,860
Goodwill 80,057 79,749
Intangible assets, net 32,225 33,121
Separate accounts assets 4,639 4,459
Other assets 4,682 4,600
Total assets 235,495 222,449
Liabilities:    
Accounts payable 9,919 10,492
Pharmacy claims and discounts payable 15,541 13,601
Health care costs payable 7,362 6,879
Policyholders’ funds 3,636 2,991
Accrued expenses 15,634 12,133
Other insurance liabilities 1,644 1,830
Current portion of operating lease liabilities 1,766 1,596
Current portion of long-term debt 8,192 3,781
Total current liabilities 63,694 53,303
Long-term operating lease liabilities 18,612 18,926
Long-term debt 63,481 64,699
Deferred income taxes 7,136 7,294
Separate accounts liabilities 4,639 4,459
Other long-term insurance liabilities 7,270 7,436
Other long-term liabilities 2,308 2,162
Total liabilities 167,140 158,279
Shareholders’ equity:    
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,732 shares issued and 1,307 shares outstanding at June 30, 2020 and 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and capital surplus 46,276 45,972
Treasury stock, at cost: 425 shares at both June 30, 2020 and December 31, 2019 (28,235) (28,235)
Retained earnings 48,768 45,108
Accumulated other comprehensive income 1,213 1,019
Total CVS Health shareholders’ equity 68,022 63,864
Noncontrolling interests 333 306
Total shareholders’ equity 68,355 64,170
Total liabilities and shareholders’ equity $ 235,495 $ 222,449